"Drug-Eluting Stents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Stents that are covered with materials that are embedded with chemicals that are gradually released into the surrounding milieu.
| Descriptor ID |
D054855
|
| MeSH Number(s) |
E07.695.750.500
|
| Concept/Terms |
Drug-Eluting Stents- Drug-Eluting Stents
- Drug Eluting Stents
- Drug-Eluting Stent
- Stent, Drug-Eluting
- Stents, Drug-Eluting
- Stents, Drug Eluting
Drug-Coated Stents- Drug-Coated Stents
- Drug Coated Stents
- Drug-Coated Stent
- Stent, Drug-Coated
- Stents, Drug-Coated
- Stents, Drug Coated
|
Below are MeSH descriptors whose meaning is more general than "Drug-Eluting Stents".
Below are MeSH descriptors whose meaning is more specific than "Drug-Eluting Stents".
This graph shows the total number of publications written about "Drug-Eluting Stents" by people in this website by year, and whether "Drug-Eluting Stents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 0 | 1 |
| 2008 | 2 | 1 | 3 |
| 2009 | 2 | 1 | 3 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 4 | 2 | 6 |
| 2013 | 1 | 2 | 3 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 0 | 3 | 3 |
| 2017 | 3 | 1 | 4 |
| 2018 | 3 | 2 | 5 |
| 2019 | 6 | 3 | 9 |
| 2020 | 0 | 1 | 1 |
| 2021 | 3 | 1 | 4 |
| 2022 | 1 | 0 | 1 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Drug-Eluting Stents" by people in Profiles.
-
Intravascular imaging guided versus coronary angiography guided percutaneous coronary intervention: systematic review and meta-analysis. BMJ. 2023 11 16; 383:e077848.
-
Safety and Efficacy of Everolimus-Eluting Bioresorbable Vascular Scaffold Versus Second-Generation Drug-Eluting Stents in Real-World Practice. J Korean Med Sci. 2023 Feb 06; 38(5):e34.
-
Thirty-Day Outcomes of Resolute Onyx Stent for Symptomatic Intracranial Stenosis: A Multicenter Propensity Score-Matched Comparison With Stenting Versus Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis Trial. Neurosurgery. 2023 06 01; 92(6):1155-1162.
-
More reassuring safety data regarding paclitaxel-eluting technologies in lower extremity revascularization. J Vasc Surg. 2022 02; 75(2):608-609.
-
Factors Influencing Reintervention Following Ductal Artery Stent Implantation for Ductal-Dependent Pulmonary Blood Flow: Results From the Congenital Cardiac Research Collaborative. Circ Cardiovasc Interv. 2021 12; 14(12):e010086.
-
In-Stent Restenosis in Saphenous Vein Grafts (from the DIVA Trial). Am J Cardiol. 2022 01 01; 162:24-30.
-
Cancer treatment resumption in patients with new-generation drug-eluting stents. Coron Artery Dis. 2021 Jun 01; 32(4):295-301.
-
Temporal Changes and Institutional Variation in Use of Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease in the United States: An NCDR Research to Practice Project. JAMA Cardiol. 2021 05 01; 6(5):574-580.
-
Update on coronary artery bioresorbable vascular scaffolds in percutaneous coronary revascularization. Rev Cardiovasc Med. 2021 Mar 30; 22(1):137-145.
-
Coronary artery aneurysms: outcomes following medical, percutaneous interventional and surgical management. Open Heart. 2021 02; 8(1).